Pharmaxis entered two distribution and marketing agreements for its asthma diagnostic and lead product, Aridol™ with Nigaard Pharma and Trimedal. Nigaard Pharma will distribute and market Aridol in Scandinavia and Trimedal will commercialize Aridol in Switzerland and Liechtenstein.